ApexBio (1733.TW) monthly revenue, September 2026
ApexBio reported revenue of NT$0.14bn for September 2026, down 4.8% from the previous month and down 23.0% from a year earlier. Year-to-date revenue was NT$1.42bn, down 5.8% year on year. It ranked 135 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.
| Month | Revenue NT$bn | MoM % | YoY % |
|---|---|---|---|
| September 2026 | 0.14 | -4.8 | -23.0 |